pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,571 catalysts · 5,256 phase readout · 2,309 8k filing · 315 pdufa · 259 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 38 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: recall×type: phase readout×type: pdufa×clear all
type
  • phase readout5,256
  • 8k filing2,309
  • pdufa315
  • earnings259
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›ACTIVE_NOT_RECRUITINGphase readoutNCT05864248: Feasibility Study SA of the Supira System for HRPCI

Sponsor: Supira Medical. Phase: NA. Conditions: Heart Diseases, Coronary Artery Disease (CAD), Heart Failure

full page →ctgov ↗
›COMPLETEDphase readoutNCT06912555: Effect of Low-calorie Diets With Different Macronutrient Composition and Macronutrient Distribution in Shift Workers With Prediabetes or Type 2 Diabetes and Overweight or Obesity.

Sponsor: Universidad de Zaragoza. Phase: NA. Conditions: Type 2 Diabetes, Overweight or Obesity, PreDiabetes

full page →ctgov ↗
›RECRUITINGphase readoutNCT07415655: Modulation of Cerebral Ischemia by Albumin

Sponsor: University Hospital Hradec Kralove. Phase: PHASE2. Conditions: Ischemic Stroke

full page →ctgov ↗
›RECRUITINGphase readoutNCT06246955: Acceptance and Commitment Therapy and Compassion-Based Virtual Group Therapy to Improve Psychological Wellbeing in Patients With Cancer

Sponsor: Mayo Clinic. Phase: NA. Conditions: Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm

full page →ctgov ↗
›RECRUITINGphase readoutNCT06843226: A Study in Children and Teenagers to Learn if a TDV Dengue Vaccination Lowers the Chance of Hospital Stays for Dengue

Sponsor: Takeda. Phase: . Conditions: Dengue Fever

full page →ctgov ↗
›RECRUITINGphase readoutNCT07420478: TF-CBT for Autistic Youth Pilot Implementation - Open Pilot

Sponsor: Dartmouth-Hitchcock Medical Center. Phase: NA. Conditions: Autism Spectrum Disorder, PTSD and Trauma-related Symptoms, Autism, Trauma and Stressor Related Disorders, Mental Health Services

full page →ctgov ↗
›RECRUITINGphase readoutNCT07164378: International Study of the SING IMT™ Prosthesis in Pseudophakic patiEnts With Stable Moderate to Profound Bilateral Central vIsion Impairment Due to adVancEd AMD / PERSPECTIVE Study

Sponsor: VisionCare, Inc.. Phase: NA. Conditions: Age - Related Macular Degeneration (AMD)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06620185: GEneRating Mucosal Immunity After INfluenzA Infection and Vaccination in Lung and Lymphoid TissuE

Sponsor: Imperial College London. Phase: NA. Conditions: Influenza

full page →ctgov ↗
›RECRUITINGphase readoutNCT06680843: Characterization of Human Immune Signatures to Zoonotic Virus Exposure in Cambodia

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: . Conditions: Immunity, Humoral

full page →ctgov ↗
›COMPLETEDphase readoutNCT07616843: STANDARDIZATION OF THE PROTOCOL FOR ATTENUATION COEFFICIENT MEASUREMENT

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia. Phase: . Conditions: Liver Steatosis

full page →ctgov ↗
›COMPLETEDphase readoutNCT03850743: Biomarker Signatures of the Sleep-pain Enigma

Sponsor: Defense and Veterans Center for Integrative Pain Management. Phase: . Conditions: Post Surgical Pain and Sleep Impairment

full page →ctgov ↗
›RECRUITINGphase readoutNCT07441343: Effects of Polyphenol Supplementation and Exercise on Physical Performance in Older Adults

Sponsor: Dr. Chris McGlory, PhD. Phase: NA. Conditions: Sarcopenia, Aging, Frailty

full page →ctgov ↗
›RECRUITINGphase readoutNCT07377643: IBI354 With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer

Sponsor: Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.. Phase: PHASE3. Conditions: HER2-positive Breast Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT01942343: Akathisia in Post Operative Outpatients Surgery

Sponsor: University Hospital, Strasbourg, France. Phase: PHASE3. Conditions: Akathisia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07642843: CM336 for Active Sjogren's Syndrome Study

Sponsor: Keymed Biosciences Co.Ltd. Phase: PHASE1. Conditions: Primary Sjögren's Syndrome (pSS)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06967415: Comparison of Pain, Sensitisation, Function and Quality of Life According to Stenosis Degree in Chronic Neck Pain

Sponsor: Izmir Democracy University. Phase: NA. Conditions: Central Sensitisation, Cervical Spine Stenosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07054515: A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis

Sponsor: Azafaros B.V.. Phase: PHASE3. Conditions: Niemann-Pick Type C Disease, GM1 Gangliosidosis, GM2 Gangliosidosis

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT06924515: The Application Value of Intercostal Suturing in Preventing Postoperative Thoracoscopic Lung Resection Chest Wall Pulmonary Hernia

Sponsor: Mingjian Ge. Phase: NA. Conditions: VATS, Lung Hernia

full page →ctgov ↗
›RECRUITINGphase readoutNCT06159335: 18F-FLUC PET/MR in Patients With Brain Mets

Sponsor: University of Wisconsin, Madison. Phase: PHASE3. Conditions: Brain Metastasis, Radiation Therapy, Immunotherapy, Active

full page →ctgov ↗
›COMPLETEDphase readoutNCT04197908: EUS-guided Gallbladder Drainage Instead of Laparoscopic Cholecystectomy for Acute Cholecystitis. A Feasibility Study.

Sponsor: Chinese University of Hong Kong. Phase: NA. Conditions: Acute Cholecystitis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07210125: Implementation and Deliver of Lenacapavir for PrEP in a Community Pharmacy Setting

Sponsor: Kelley-Ross & Associates, Inc.. Phase: PHASE4. Conditions: HIV

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07423325: Validation of Skin Instrumentation to Detect Ceramide-Driven Lipid Replenishment - Assessing Skin Glow, Hydration, Trans Epidermal Water Loss, Skin Surface Assessment, Sebum and Least-Reflection Factor.

Sponsor: NovoBliss Research Pvt Ltd. Phase: NA. Conditions: Dry and Sensitive Skin

full page →ctgov ↗
›RECRUITINGphase readoutNCT05274425: A 24-week rPMS Study in Real-world Setting for Enerzair

Sponsor: Novartis Pharmaceuticals. Phase: . Conditions: Asthma

full page →ctgov ↗
›RECRUITINGphase readoutNCT05266976: Mode of Exercise and Bone Biomarkers in Older Veterans

Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Aging, Musculoskeletal Diseases, Osteoporosis

full page →ctgov ↗
›COMPLETEDphase readoutNCT06719076: IMPACT OF DIABETES HEALTHCARE PROGRAM ON GLYCEMIC CONTROL, SELF-EFFICACY AND DIABETES KNOWLEDGE AMONG TYPE-II DIABETICS IN ISLAMABAD PAKISTAN

Sponsor: Health Services Academy, Islamabad, Pakistan. Phase: NA. Conditions: HbA1c, Self-Efficacy, Diabetes Knowledge

full page →ctgov ↗
›RECRUITINGphase readoutNCT07228117: GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes

Sponsor: Medtronic MiniMed, Inc.. Phase: NA. Conditions: Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07485517: Deep Versus Moderate Neuromuscular Blocking

Sponsor: Menoufia University. Phase: NA. Conditions: Change in Serum Levels of the Estimated Inflammatory Cytokines, Total Dose of IO Fentanyl, PO Morphine, Surgeons' Rating, Pain Scores

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07373717: Consistency of Fluid Tolerance Evaluation Methods and Their Correlation With Clinical Outcomes in Patients With Shock

Sponsor: Southeast University, China. Phase: . Conditions: Shock

full page →ctgov ↗
›COMPLETEDphase readoutNCT06695117: Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and High-Dose Inactivated Influenza Vaccine in Adult Participants 50 Years of Age and Older

Sponsor: Sanofi. Phase: PHASE1. Conditions: COVID-19 Immunization, Influenza Immunization

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04386317: Terazosin Effect on Cardiac Changes in Early Parkinson's Disease

Sponsor: Cedars-Sinai Medical Center. Phase: PHASE2. Conditions: REM Sleep Behavior Disorder, Pre-motor Parkinson's Disease, Symptomatic Parkinson Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT05245617: Observational Study on JuniOrtho Plating System for Deformities and Fractures Treatment in Lower Limb

Sponsor: Orthofix s.r.l.. Phase: . Conditions: Deformity, Defect, Congenital, Trauma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06691217: Effects of IL-1 Beta Inhibition on Vascular Inflammation in TET2 Clonal Hematopoiesis

Sponsor: Massachusetts General Hospital. Phase: PHASE2. Conditions: Vascular Inflammation, ASCVD, ASCVD Management

full page →ctgov ↗
›TERMINATEDphase readoutNCT04587440: Is the Dynamic of the Pelvic Bone Altered After a Total Hip Replacement ?

Sponsor: University Hospital, Brest. Phase: NA. Conditions: Coxarthrosis; Primary, Coxarthrosis; Secondary

full page →ctgov ↗
›RECRUITINGphase readoutNCT07290140: Paclitaxel-Coated Balloon Treatment of Chronic Rhinosinusitis

Sponsor: Airiver Medical, Inc.. Phase: NA. Conditions: Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps

full page →ctgov ↗
›COMPLETEDphase readoutNCT05861089: Rest PETCO2 as a Predictor of Post-operative Complications

Sponsor: St. Anne's University Hospital Brno, Czech Republic. Phase: . Conditions: Post-Op Complication

full page →ctgov ↗
›RECRUITINGphase readoutNCT06163989: Protecting the Eyes of Gamers With Lubricating Eyedrops

Sponsor: Aston University. Phase: NA. Conditions: Dry Eye Syndromes, Computer Vision Syndrome

full page →ctgov ↗
›RECRUITINGphase readoutNCT07428889: Nicotinamide Adenine Dinucleotide Responses to a Nutritional Supplement

Sponsor: Shaklee Corporation. Phase: NA. Conditions: Healthy Adult

full page →ctgov ↗
›RECRUITINGphase readoutNCT00801489: Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE2. Conditions: Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1, de Novo Myelodysplastic Syndrome, High Risk Myelodysplastic Syndrome, Inv(16), Myelodysplastic Syndrome With Excess Blasts, t(16;16), t(8;21), Untreated Adult Acute Myeloid Leukemia

full page →ctgov ↗
›COMPLETEDphase readoutNCT06005168: Comparison of a Morphomic-Based to the Standard-of-Care-Based Cefazolin Dose for Antimicrobial Prophylaxis

Sponsor: University of Michigan. Phase: PHASE4. Conditions: Surgical Prophylaxis

full page →ctgov ↗
›RECRUITINGphase readoutNCT05277168: A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF SHR-A1904 IN SUBJECTS WITH ADVANCED SOLID TUMORS

Sponsor: Jiangsu HengRui Medicine Co., Ltd.. Phase: PHASE1. Conditions: Advanced Solid Tumors

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07506668: RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas

Sponsor: Affiliated Hospital of Nantong University. Phase: PHASE1. Conditions: Relapsed/Refractory B-cell Lymphoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT03896568: MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma

Sponsor: M.D. Anderson Cancer Center. Phase: PHASE1. Conditions: IDH1 wt Allele, Recurrent Anaplastic Astrocytoma, Recurrent Glioblastoma, Recurrent Gliosarcoma, Recurrent Malignant Glioma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07472959: Effect of Intraoperative Morphine on Postoperative Pain After CABG

Sponsor: Istanbul University - Cerrahpasa. Phase: PHASE4. Conditions: Cardiac Surgery Patient, Postoperative Pain, Pain After Surgery

full page →ctgov ↗
›RECRUITINGphase readoutNCT07151859: Clinical Investigation on a Polynucleotide-based Device Used to Improve Skin Hydration

Sponsor: Mastelli S.r.l. Phase: NA. Conditions: Aesthetic Improvement of the Skin, Skin Hydration in Healthy Volunteers, Skin Elasticity, Skin Turgor, Subject Satisfaction

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07649759: Mindfulness-Based Nutrition Group Therapy as an Adjunct to GLP-1 Treatment of Obesity

Sponsor: Bern University of Applied Sciences. Phase: NA. Conditions: Obesity & Overweight, Emotional Eating Behaviour, Mindful Eating Intervention

full page →ctgov ↗
›COMPLETEDphase readoutNCT07434362: Serum Endocan, Alarin, and Galanin-Like Peptide Levels in Diabetic Retinopathy

Sponsor: Elazıg Fethi Sekin Sehir Hastanesi. Phase: NA. Conditions: Diabetic Retinopathy, Diabetes Mellitus, Retinal Microvascular Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT07180862: A Study Evaluating BAT3306 Compared With Keytruda® in NSCLC Cancer Participants

Sponsor: Bio-Thera Solutions. Phase: PHASE1. Conditions: Carcinoma, Non-Small-Cell Lung

full page →ctgov ↗
›RECRUITINGphase readoutNCT06477146: Milk Thistle Clinical Trial in Pediatric NAFLD

Sponsor: University Hospitals Cleveland Medical Center. Phase: PHASE2. Conditions: Non-Alcoholic Fatty Liver Disease (NAFLD)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT01802346: Controlled Low Calorie Diet in Reducing Side Effects and Increasing Response to Chemotherapy in Patients With Breast or Prostate Cancer

Sponsor: University of Southern California. Phase: NA. Conditions: Breast Cancer, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07662603: Behcet Disease Patients With Pulmonary Endoarterectomy: Outcomes of Program of Inspiratory Msucle Trianing

Sponsor: Cairo University. Phase: NA. Conditions: Behcet Disease

full page →ctgov ↗
← prev
page 103 of 112
next →